Share-based Payment Arrangement, Expense of NEUROONE MEDICAL TECHNOLOGIES Corp from 30 Jun 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2017 to 31 Dec 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $359,255, a 5.9% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $1,284,639, a 6.6% decline year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Share-based Payment Arrangement, Expense for 2025 was $1,264,608, a 5.9% decline from 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Share-based Payment Arrangement, Expense for 2024 was $1,344,476, a 22% increase from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Share-based Payment Arrangement, Expense for 2023 was $1,105,457, a 17% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,284,639 $359,255 +$20,031 +5.9% 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q1
Q3 2025 $1,264,608 $358,560 +$18,189 +5.3% 01 Jul 2025 30 Sep 2025 10-K 17 Dec 2025 2025 FY
Q2 2025 $1,246,419 $316,654 -$21,955 -6.5% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 $1,268,374 $250,170 -$106,688 -30% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 $1,375,062 $339,224 +$30,586 +9.9% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q1
Q3 2024 $1,344,476 $340,371 +$69,125 +25% 01 Jul 2024 30 Sep 2024 10-K 17 Dec 2025 2025 FY
Q2 2024 $1,275,351 $338,609 +$42,207 +14% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q3
Q1 2024 $1,233,144 $356,858 +$119,230 +50% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q2
Q4 2023 $1,113,914 $308,638 +$8,457 +2.8% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2025 Q1
Q3 2023 $1,105,457 $271,246 +$15,370 +6% 01 Jul 2023 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 $1,090,087 $296,402 +$40,854 +16% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q3
Q1 2023 $1,049,233 $237,628 +$4,912 +2.1% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q2
Q4 2022 $1,044,321 $300,181 +$97,109 +48% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2024 Q1
Q3 2022 $947,212 $255,876 -$86,283 -25% 01 Jul 2022 30 Sep 2022 10-K 15 Dec 2023 2023 FY
Q2 2022 $1,033,495 $255,548 -$623,304 -71% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q3
Q1 2022 $1,656,799 $232,716 -$93,643 -29% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q2
Q4 2021 $1,750,442 $203,072 -$42,757 -17% 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023 2023 Q1
Q3 2021 $1,793,199 $342,159 +$9,330 +2.8% 01 Jul 2021 30 Sep 2021 10-K 22 Dec 2022 2022 FY
Q2 2021 $1,783,869 $878,852 +$495,169 +129% 01 Apr 2021 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 $1,288,700 $326,359 -$205,422 -39% 01 Jan 2021 31 Mar 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 $1,494,122 $245,829 -$341,848 -58% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q1
Q3 2020 $1,835,970 $332,829 +$262,365 +372% 01 Jul 2020 30 Sep 2020 10-K/A 31 May 2022 2021 FY
Q2 2020 $1,573,605 $383,683 +$151,595 +65% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q3
Q1 2020 $1,422,010 $531,781 +$461,564 +657% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q2
Q4 2019 $960,446 $587,677 +$468,697 +394% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021 2021 Q1
Q3 2019 $491,749 $70,464 01 Jul 2019 30 Sep 2019 10-K 09 Dec 2020 2020 FY
Q2 2019 $232,088 +$112,578 +94% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q3
Q1 2019 $70,217 -$184,220 -72% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q2
Q4 2018 $118,980 01 Oct 2018 31 Dec 2018 10-Q 14 Feb 2020 2020 Q1
Q2 2018 $119,510 +$107,661 +909% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q3
Q1 2018 $254,437 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q2
Q3 2017 $64,945 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $11,849 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018 2018 Q2

NEUROONE MEDICAL TECHNOLOGIES Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,264,608 -$79,868 -5.9% 01 Oct 2024 30 Sep 2025 10-K 17 Dec 2025 2025 FY
2024 $1,344,476 +$239,019 +22% 01 Oct 2023 30 Sep 2024 10-K 17 Dec 2025 2025 FY
2023 $1,105,457 +$158,245 +17% 01 Oct 2022 30 Sep 2023 10-K 17 Dec 2024 2024 FY
2022 $947,212 -$845,987 -47% 01 Oct 2021 30 Sep 2022 10-K 15 Dec 2023 2023 FY
2021 $1,793,199 -$42,771 -2.3% 01 Oct 2020 30 Sep 2021 10-K 22 Dec 2022 2022 FY
2020 $1,835,970 +$1,344,221 +273% 01 Oct 2019 30 Sep 2020 10-K/A 31 May 2022 2021 FY
2019 $491,749 01 Oct 2018 30 Sep 2019 10-K 09 Dec 2020 2020 FY
2017 $76,794 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.